Septerna, Inc. (SEPN)
(Delayed Data from NSDQ)
$12.21 USD
-0.20 (-1.61%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $12.19 -0.02 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Septerna, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SEPN 12.21 -0.20(-1.61%)
Will SEPN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SEPN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SEPN
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?
ETFs to Capitalize on the Novo Nordisk-Septerna Deal
SEPN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk
Wall Street Analysts Predict a 207.31% Upside in Septerna, Inc. (SEPN): Here's What You Should Know
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
Other News for SEPN
Septerna (SEPN) Receives Buy Rating with Promising Outlook | SEPN Stock News
Septerna initiated with a Buy at H.C. Wainwright
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
The Analyst Verdict: Septerna In The Eyes Of 4 Experts